These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 9350868)

  • 1. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments.
    Frithz-Lindsten E; Du Y; Rosqvist R; Forsberg A
    Mol Microbiol; 1997 Sep; 25(6):1125-39. PubMed ID: 9350868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exoenzyme T of Pseudomonas aeruginosa elicits cytotoxicity without interfering with Ras signal transduction.
    Sundin C; Henriksson ML; Hallberg B; Forsberg A; Frithz-Lindsten E
    Cell Microbiol; 2001 Apr; 3(4):237-46. PubMed ID: 11298647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular expression of the ADP-ribosyltransferase domain of Pseudomonas exoenzyme S is cytotoxic to eukaryotic cells.
    Pederson KJ; Barbieri JT
    Mol Microbiol; 1998 Nov; 30(4):751-9. PubMed ID: 10094623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Yersinia Yop-effector delivery by translocated YopE.
    Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
    Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence.
    Black DS; Bliska JB
    Mol Microbiol; 2000 Aug; 37(3):515-27. PubMed ID: 10931345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.
    Pederson KJ; Vallis AJ; Aktories K; Frank DW; Barbieri JT
    Mol Microbiol; 1999 Apr; 32(2):393-401. PubMed ID: 10231494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecto-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exoenzyme S.
    Knight DA; Barbieri JT
    Infect Immun; 1997 Aug; 65(8):3304-9. PubMed ID: 9234791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of Ras in eukaryotic cells by Pseudomonas aeruginosa exoenzyme S.
    McGuffie EM; Frank DW; Vincent TS; Olson JC
    Infect Immun; 1998 Jun; 66(6):2607-13. PubMed ID: 9596723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADP-ribosylation by exoenzyme T of Pseudomonas aeruginosa induces an irreversible effect on the host cell cytoskeleton in vivo.
    Sundin C; Hallberg B; Forsberg A
    FEMS Microbiol Lett; 2004 May; 234(1):87-91. PubMed ID: 15109724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.
    Henriksson ML; Rosqvist R; Telepnev M; Wolf-Watz H; Hallberg B
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):217-22. PubMed ID: 10727422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The exoenzyme S regulon of Pseudomonas aeruginosa.
    Frank DW
    Mol Microbiol; 1997 Nov; 26(4):621-9. PubMed ID: 9427393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia.
    Rangel SM; Logan LK; Hauser AR
    mBio; 2014 Jun; 5(3):e01080-14. PubMed ID: 24917597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent and coordinate effects of ADP-ribosyltransferase and GTPase-activating activities of exoenzyme S on HT-29 epithelial cell function.
    Fraylick JE; La Rocque JR; Vincent TS; Olson JC
    Infect Immun; 2001 Sep; 69(9):5318-28. PubMed ID: 11500401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.
    Maresso AW; Deng Q; Pereckas MS; Wakim BT; Barbieri JT
    Cell Microbiol; 2007 Jan; 9(1):97-105. PubMed ID: 16889625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of recombinant exoenzyme S of Pseudomonas aeruginosa.
    Kulich SM; Frank DW; Barbieri JT
    Infect Immun; 1995 Jan; 63(1):1-8. PubMed ID: 7806344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS.
    Riese MJ; Goehring UM; Ehrmantraut ME; Moss J; Barbieri JT; Aktories K; Schmidt G
    J Biol Chem; 2002 Apr; 277(14):12082-8. PubMed ID: 11821389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.
    Yahr TL; Barbieri JT; Frank DW
    J Bacteriol; 1996 Mar; 178(5):1412-9. PubMed ID: 8631719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity.
    Saleeb M; Sundin C; Aglar Ö; Pinto AF; Ebrahimi M; Forsberg Å; Schüler H; Elofsson M
    Eur J Med Chem; 2018 Jan; 143():568-576. PubMed ID: 29207339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the role of actin-plasma membrane association in Pseudomonas aeruginosa infection and type III secretion translocation in migratory T24 epithelial cells.
    Bridge DR; Martin KH; Moore ER; Lee WM; Carroll JA; Rocha CL; Olson JC
    Infect Immun; 2012 Sep; 80(9):3049-64. PubMed ID: 22689823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADP-ribosylation of cyclophilin A by Pseudomonas aeruginosa exoenzyme S.
    DiNovo AA; Schey KL; Vachon WS; McGuffie EM; Olson JC; Vincent TS
    Biochemistry; 2006 Apr; 45(14):4664-73. PubMed ID: 16584201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.